Login Register Cart 0
Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Role of Medicinal Plants in Combating Anti-depressant Induced Male Infertility

Author(s): Pooja Gori, Manan Raval*, Samir Patel and Niraj Vyas

Volume 8, Issue 4, 2022

Published on: 09 June, 2022

Article ID: e210322202479 Pages: 17

DOI: 10.2174/2215083808666220321144217

Price: $65

Abstract

Depression is a complex neurological disorder. More than two hundred million people are affected by depression. Anti-depressant drugs prescribed to alleviate the symptoms associated with depression can interact with the neuroendocrine system and alter the level of neurotransmitters in the CNS. Dopamine, serotonin, testosterone, and other hormones influence human reproductive functions and sexual behavior. Anti-depressant drugs induce multiple hormonal and neurochemical changes throughout the central and peripheral nervous system. They were found to impair male sexual function by altering the concentration of androgenic hormones. Moreover, they were found to deteriorate semen parameters and adversely affect the integrity of sperm DNA. The paper describes the role of anti-depressants in inducing male infertility and the potential of traditionally used medicinal plants in restoring male fertility, which is compromised by anti-depressants. Medicinal plants have been reported to restore testosterone, FSH, and LH level in patients who consume antidepressants. Although the studies could not provide a specific mechanism, it has been reported that the plants showed the ability to upregulated anti-oxidant pathways and counter the oxidative stress induced by anti-oxidants which inhibit sperm DNA damage and improve semen parameters.

Keywords: Anti-depressant, male infertility, hypothalamic-pituitary-gonadal axis, dopamine, testosterone, medicinal plant.

Graphical Abstract

[1]
Kessler RC, Berglund P, Demler O, et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: Re-sults from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289(23): 3095-105.
[http://dx.doi.org/10.1001/jama.289.23.3095] [PMID: 12813115]
[2]
James SL, Abate D, Abate KH, et al. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A sys-tematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392(10159): 1789-858.
[http://dx.doi.org/10.1016/S0140-6736(18)32279-7] [PMID: 30496104]
[3]
Lu Y, Tang C, Liow CS, Ng WWN, Ho CSH, Ho RCM. A regressional analysis of maladaptive rumination, illness perception and negative emotional outcomes in Asian patients suffering from depressive disorder. Asian J Psychiatr 2014; 12(1): 69-76.
[http://dx.doi.org/10.1016/j.ajp.2014.06.014] [PMID: 25440564]
[4]
Ayuob NN, Ali SS, Suliaman M, El Wahab MGA, Ahmed SM. The antidepressant effect of musk in an animal model of depression: A histopathological study. Cell Tissue Res 2016; 366(2): 271-84.
[http://dx.doi.org/10.1007/s00441-016-2468-9] [PMID: 27481508]
[5]
Vos T, Allen C, Arora M, Barber RM, Brown A, Carter A. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analy-sis for the Global Burden of Disease Study 2015. Lancet 2016; 388(10053): 1545-602.
[http://dx.doi.org/10.1016/S0140-6736(16)31678-6] [PMID: 27733282]
[6]
Hendrick V, Gitlin M, Altshuler L, Korenman S. Antidepressant medications, mood and male fertility. Psychoneuroendocrinology 2000; 25(1): 37-51.
[http://dx.doi.org/10.1016/S0306-4530(99)00038-4] [PMID: 10633534]
[7]
Olivier JDA, Olivier B. Antidepressants and sexual dysfunctions: A translational perspective. Curr Sex Health Rep 2019; 11(3): 156-66.
[http://dx.doi.org/10.1007/s11930-019-00205-y]
[8]
Montgomery SA, Baldwin DS, Riley A. Antidepressant medications: A review of the evidence for drug-induced sexual dysfunction. J Affect Disord 2002; 69(1-3): 119-40.
[http://dx.doi.org/10.1016/S0165-0327(01)00313-5] [PMID: 12103459]
[9]
Werneke U, Northey S, Bhugra D. Antidepressants and sexual dysfunction. Acta Psychiatr Scand 2006; 114(6): 384-97.
[http://dx.doi.org/10.1111/j.1600-0447.2006.00890.x] [PMID: 17087787]
[10]
Brigitta B. Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci 2002; 4(1): 7-20.
[http://dx.doi.org/10.31887/DCNS.2002.4.1/bbondy] [PMID: 22033824]
[11]
Charles B. NemeroffEZOLD FA. Recent findings on the pathophysiology of hyperlipoidemia in the nephrotic syndrome. Focus (Madison) 2008; 6(1): 3-14.
[12]
Eisch AJ, Petrik D. Depression and hippocampal neurogenesis: A road to remission? Science (80- ) 2012; 338(6103): 72-5.
[http://dx.doi.org/10.1126/science.1222941]
[13]
Hammen C. Stress and depression. Annu Rev Clin Psychol 2005; 1(1): 293-319.
[http://dx.doi.org/10.1146/annurev.clinpsy.1.102803.143938] [PMID: 17716090]
[14]
Atzori M, Cuevas-Olguin R, Esquivel-Rendon E, et al. Locus ceruleus norepinephrine release: A central regulator of cns spatio-temporal activation? Front Synaptic Neurosci 2016; 8: 25.
[http://dx.doi.org/10.3389/fnsyn.2016.00025] [PMID: 27616990]
[15]
Maletic V, Eramo A, Gwin K, Offord SJ, Duffy RA. The role of norepinephrine and its α-adrenergic receptors in the pathophysiology and treatment of major depressive disorder and schizophrenia: A systematic review. Front Psychiatry 2017; 8: 42.
[http://dx.doi.org/10.3389/fpsyt.2017.00042] [PMID: 28367128]
[16]
Grace AA. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci 2016; 17(8): 524-32.
[http://dx.doi.org/10.1038/nrn.2016.57] [PMID: 27256556]
[17]
Landén M, Thase ME. A model to explain the therapeutic effects of serotonin reuptake inhibitors: The role of 5-HT2 receptors. Psychopharmacol Bull 2006; 39(1): 147-66.
[PMID: 17065978]
[18]
Coppen A. The biochemistry of affective disorders. Br J Psychiatry 1967; 113(504): 1237-64.
[http://dx.doi.org/10.1192/bjp.113.504.1237] [PMID: 4169954]
[19]
Seo D, Patrick CJ, Kennealy PJ. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggress Violent Behav 2008; 13(5): 383-95.
[http://dx.doi.org/10.1016/j.avb.2008.06.003] [PMID: 19802333]
[20]
Stahl SM. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord 1998; 51(3): 215-35.
[http://dx.doi.org/10.1016/S0165-0327(98)00221-3] [PMID: 10333979]
[21]
Keller J, Gomez R, Williams G, et al. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Mol Psychiatry 2017; 22(4): 527-36.
[http://dx.doi.org/10.1038/mp.2016.120] [PMID: 27528460]
[22]
Sher L, Oquendo MA, Burke AK, Cooper TB, Mann JJ. Combined dexamethasone suppression-corticotrophin-releasing hormone stimula-tion test in medication-free major depression and healthy volunteers. J Affect Disord 2013; 151(3): 1108-12.
[http://dx.doi.org/10.1016/j.jad.2013.06.049] [PMID: 23866302]
[23]
Holsboer F. The Corticosteroid receptor hypothesis of depression. Depress Sci Ment Heal 2013; 6: 219-44.
[24]
Lopez-Duran NL, Kovacs M, George CJ. Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: A meta-analysis. Psychoneuroendocrinology 2009; 34(9): 1272-83.
[http://dx.doi.org/10.1016/j.psyneuen.2009.03.016] [PMID: 19406581]
[25]
Gillespie CF, Nemeroff CB. Hypercortisolemia and depression. Psychosom Med 2005; 67(1)(Suppl. 1): S26-8.
[http://dx.doi.org/10.1097/01.psy.0000163456.22154.d2] [PMID: 15953796]
[26]
López León S, Croes EA, Sayed-Tabatabaei FA, Claes S, Van Broeckhoven C, van Duijn CM. The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: A meta-analysis. Biol Psychiatry 2005; 57(9): 999-1003.
[http://dx.doi.org/10.1016/j.biopsych.2005.01.030] [PMID: 15860340]
[27]
López-León S, Janssens ACJW, González-Zuloeta Ladd AM, et al. Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 2008; 13(8): 772-85.
[http://dx.doi.org/10.1038/sj.mp.4002088] [PMID: 17938638]
[28]
Yuan Y, Zhang Z, Bai F, et al. Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression. J Affect Disord 2010; 121(3): 273-7.
[http://dx.doi.org/10.1016/j.jad.2009.07.003] [PMID: 19647324]
[29]
Qiu A, Taylor WD, Zhao Z, et al. APOE related hippocampal shape alteration in geriatric depression. Neuroimage 2009; 44(3): 620-6.
[http://dx.doi.org/10.1016/j.neuroimage.2008.10.010] [PMID: 19010425]
[30]
Buckley P. Apolipoprotein E ε4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: The honolulu-asia aging study. Yearb Psychiatry Appl Ment Heal 2009; 2009(8): 331-2.
[http://dx.doi.org/10.1016/S0084-3970(08)79264-8]
[31]
Dannlowski U, Ohrmann P, Bauer J, et al. Serotonergic genes modulate amygdala activity in major depression. Genes Brain Behav 2007; 6(7): 672-6.
[http://dx.doi.org/10.1111/j.1601-183X.2006.00297.x] [PMID: 17284168]
[32]
Smolka MN, Bühler M, Schumann G, et al. Gene-gene effects on central processing of aversive stimuli. Mol Psychiatry 2007; 12(3): 307-17.
[http://dx.doi.org/10.1038/sj.mp.4001946] [PMID: 17211439]
[33]
Paykel ES, Cooper Z, Ramana R, Hayhurst H. Life events, social support and marital relationships in the outcome of severe depression. Psychol Med 1996; 26(1): 121-33.
[http://dx.doi.org/10.1017/S0033291700033766] [PMID: 8643751]
[34]
Kessler RC. The effects of stressful life events on depression. Annu Rev Psychol 1997; 48(1): 191-214.
[http://dx.doi.org/10.1146/annurev.psych.48.1.191] [PMID: 9046559]
[35]
Henn FA, Vollmayr B. Neurogenesis and depression: Etiology or epiphenomenon? Biol Psychiatry 2004; 56(3): 146-50.
[http://dx.doi.org/10.1016/j.biopsych.2004.04.011] [PMID: 15271582]
[36]
Gandy K, Kim S, Sharp C, Dindo L, Maletic-Savatic M, Calarge C. Pattern separation: A potential marker of impaired hippocampal adult neurogenesis in major depressive disorder. Front Neurosci 2017; 11: 571.
[http://dx.doi.org/10.3389/fnins.2017.00571] [PMID: 29123464]
[37]
Molendijk ML, Spinhoven P, Polak M, Bus BAA, Penninx B, Elzinga BM. Serum BDNF concentrations as peripheral manifestations of depression: Evidence from a systematic review and meta-analyses on 179 associations (N 1/4 9484). Mol Psychiatry 2013; 19(7): 791-800.
[http://dx.doi.org/10.1038/mp.2013.105] [PMID: 23958957]
[38]
Hashioka S, Inoue K, Hayashida M, Wake R, Oh-Nishi A, Miyaoka T. Implications of systemic inflammation and periodontitis for major depression. Front Neurosci 2018; 12: 483.
[http://dx.doi.org/10.3389/fnins.2018.00483] [PMID: 30072865]
[39]
Bollen J, Trick L, Llewellyn D, Dickens C. The effects of acute inflammation on cognitive functioning and emotional processing in hu-mans: A systematic review of experimental studies. J Psychosom Res 2017; 94: 47-55.
[http://dx.doi.org/10.1016/j.jpsychores.2017.01.002] [PMID: 28183402]
[40]
Miller AH, Raison CL. The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nat Rev Immunol 2016; 16(1): 22-34.
[http://dx.doi.org/10.1038/nri.2015.5] [PMID: 26711676]
[41]
Setiawan E, Wilson AA, Mizrahi R, et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 2015; 72(3): 268-75.
[http://dx.doi.org/10.1001/jamapsychiatry.2014.2427]
[42]
Waldinger MD, Zwinderman AH, Olivier B. SSRIs and ejaculation: A double-blind, randomized, fixed-dose study with paroxetine and citalopram. J Clin Psychopharmacol 2001; 21(6): 556-60.
[http://dx.doi.org/10.1097/00004714-200112000-00003] [PMID: 11763001]
[43]
Baldwin D, Mayers A. Sexual side-effects of antidepressant and antipsychotic drugs. Adv Psychiatr Treat 2003; 9(3): 202-10.
[http://dx.doi.org/10.1192/apt.9.3.202]
[44]
Samplaski MK, Nangia AK. Adverse effects of common medications on male fertility. Nat Rev Urol 2015; 12(7): 401-13.
[http://dx.doi.org/10.1038/nrurol.2015.145] [PMID: 26101108]
[45]
Gillman PK. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol 2007; 151(6): 737-48.
[http://dx.doi.org/10.1038/sj.bjp.0707253] [PMID: 17471183]
[46]
Baker GB, Coutts RT, McKenna KF, Sherry-McKenna RL. Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: A review. J Psychiatry Neurosci 1992; 17(5): 206-14.
[PMID: 1362653]
[47]
Ferguson JM. SSRI antidepressant medications: Adverse effects and tolerability. Prim Care Companion J Clin Psychiatry 2001; 3(1): 22-7.
[http://dx.doi.org/10.4088/PCC.v03n0105] [PMID: 15014625]
[48]
Riggin LKG. Effects of selective serotonin reuptake inhibitors on sperm and male fertility. Can Fam Physician 2015; 61(6): 529-30.
[49]
Müller T. Mechanism of action of anticholinergics. Aktuelle Neurol 1998; 25(4): 123-32.
[50]
Lambert O, Bourin M. SNRIs: Mechanism of action and clinical features. Expert Rev Neurother 2002; 2(6): 849-58.
[http://dx.doi.org/10.1586/14737175.2.6.849] [PMID: 19810918]
[51]
Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 2004; 6(4): 159-66.
[http://dx.doi.org/10.4088/PCC.v06n0403] [PMID: 15361919]
[52]
Beeder LA, Samplaski MK. Effect of antidepressant medications on semen parameters and male fertility. Int J Urol 2020; 27(1): 39-46.
[http://dx.doi.org/10.1111/iju.14111] [PMID: 31542895]
[53]
Horst WD, Preskorn SH. Mechanisms of action and clinical characteristics of three atypical antidepressants: Venlafaxine, nefazodone, bupropion. J Affect Disord 1998; 51(3): 237-54.
[http://dx.doi.org/10.1016/S0165-0327(98)00222-5] [PMID: 10333980]
[54]
Hickie IB, Rogers NL. Novel melatonin-based therapies: Potential advances in the treatment of major depression. Lancet 2011; 378(9791): 621-31.
[http://dx.doi.org/10.1016/S0140-6736(11)60095-0] [PMID: 21596429]
[55]
Giuliano F, Allard J. Dopamine and male sexual function. Eur Urol 2001; 40(6): 601-8.
[http://dx.doi.org/10.1159/000049844] [PMID: 11805404]
[56]
Serotonin DS, Dysfunction SJ. Autacoids 2014; 05(01): 1-2.
[57]
Clement P, Giuliano F. Physiology and pharmacology of ejaculation. Basic Clin Pharmacol Toxicol 2016; 119(Suppl. 3): 18-25.
[http://dx.doi.org/10.1111/bcpt.12546] [PMID: 26709195]
[58]
Giuliano F, Clèment P. Pharmacology for the treatment of premature ejaculation. Pharmacol Rev 2012; 64(3): 621-44.
[http://dx.doi.org/10.1124/pr.111.004952] [PMID: 22679220]
[59]
Gladkova AI. Role of neurotransmitters in coordination of male sexual behavior. Neurophysiology 2000; 32(1): 57-61.
[http://dx.doi.org/10.1007/BF02515169] [PMID: 10899183]
[60]
Ajayi AF, Akhigbe RE. The physiology of male reproduction: Impact of drugs and their abuse on male fertility. Andrologia 2020; 52(9): e13672.
[http://dx.doi.org/10.1111/and.13672] [PMID: 32542870]
[61]
Corradi PF, Corradi RB, Greene LW. Physiology of the hypothalamic pituitary gonadal axis in the male. Urol Clin North Am 2016; 43(2): 151-62.
[http://dx.doi.org/10.1016/j.ucl.2016.01.001] [PMID: 27132572]
[62]
Dhillo WS, Chaudhri OB, Patterson M, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab 2005; 90(12): 6609-15.
[http://dx.doi.org/10.1210/jc.2005-1468] [PMID: 16174713]
[63]
Trarbach EB, Silveira LG, Latronico AC. Genetic insights into human isolated gonadotropin deficiency. Pituitary 2007; 10(4): 381-91.
[http://dx.doi.org/10.1007/s11102-007-0061-7] [PMID: 17624596]
[64]
Miura C, Miura T. Analysis of spermatogenesis using an Eel model. Aqua-Biosci Monogr 2011; 4(4): 105-29.
[http://dx.doi.org/10.5047/absm.2011.00404.0105]
[65]
Wetsel WC, Valença MM, Merchenthaler I, et al. Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hor-mone-secreting neurons. Proc Natl Acad Sci USA 1992; 89(9): 4149-53.
[http://dx.doi.org/10.1073/pnas.89.9.4149] [PMID: 1570341]
[66]
O’Shaughnessy PJ, Monteiro A, Verhoeven G, De Gendt K, Abel MH. Effect of FSH on testicular morphology and spermatogenesis in gonadotrophin-deficient hypogonadal mice lacking androgen receptors. Reproduction 2010; 139(1): 177-84.
[http://dx.doi.org/10.1530/REP-09-0377] [PMID: 19846485]
[67]
Bilezikjian LM, Blount AL, Leal AMO, Donaldson CJ, Fischer WH, Vale WW. Autocrine/paracrine regulation of pituitary function by activin, inhibin and follistatin. Mol Cell Endocrinol 2004; 225(1-2): 29-36.
[http://dx.doi.org/10.1016/j.mce.2004.02.010] [PMID: 15451565]
[68]
Un-Nahar Z, Ali M, Biswas S, Kamrun N, Bashar T, Arslan M. Study of seminal MDA level as a oxidative stress marker in infertile male. J Sci Found 2013; 9(1-2): 85-93.
[http://dx.doi.org/10.3329/jsf.v9i1-2.14651]
[69]
Wiwanitkit V. Difference in physiogenomics between male and female infertility. Andrologia 2008; 40(3): 158-60.
[http://dx.doi.org/10.1111/j.1439-0272.2008.00839.x] [PMID: 18477202]
[70]
Sinclair S. Male infertility: Nutritional and environmental considerations. Altern Med Rev 2000; 5(1): 28-38.
[PMID: 10696117]
[71]
O’Flynn O’Brien KL, Varghese AC, Agarwal A. The genetic causes of male factor infertility: A review. Fertil Steril 2010; 93(1): 1-12.
[http://dx.doi.org/10.1016/j.fertnstert.2009.10.045] [PMID: 20103481]
[72]
Durairajanayagam D. Lifestyle causes of male infertility. Arab J Urol 2018; 16(1): 10-20.
[http://dx.doi.org/10.1016/j.aju.2017.12.004] [PMID: 29713532]
[73]
Karavolos S, Stewart J, Evbuomwan I, McEleny K, Aird I. Assessment of the infertile male. Obstet Gynaecol 2013; 15(1): 1-9.
[http://dx.doi.org/10.1111/j.1744-4667.2012.00145.x]
[74]
Bergh SJ, Giraldi A. Sexual dysfunction associated with antidepressant agents. Ugeskr Laeger 2014; 176(22): 457-70.
[PMID: 25352006]
[75]
Schreiner-Engel P, Schiavi RC. Lifetime psychopathology in individuals with low sexual desire. J Nerv Ment Dis 1986; 174(11): 646-51.
[http://dx.doi.org/10.1097/00005053-198611000-00002] [PMID: 3772353]
[76]
Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am J Cardiol 2000; 86(2A): 41F-5F.
[http://dx.doi.org/10.1016/S0002-9149(00)00892-4] [PMID: 10899278]
[77]
Derogatis LR, Meyer JK, King KM. Psychopathology in individuals with sexual dysfunction. Am J Psychiatry 1981; 138(6): 757-63.
[http://dx.doi.org/10.1176/ajp.138.6.757] [PMID: 7246804]
[78]
Casper RC, Redmond DE Jr, Katz MM, Schaffer CB, Davis JM, Koslow SH. Somatic symptoms in primary affective disorder. Presence and relationship to the classification of depression. Arch Gen Psychiatry 1985; 42(11): 1098-104.
[http://dx.doi.org/10.1001/archpsyc.1985.01790340082012] [PMID: 3863548]
[79]
Ernst C, Földényi M, Angst J. The Zurich Study: XXI. Sexual dysfunctions and disturbances in young adults. Data of a longitudinal epi-demiological study. Eur Arch Psychiatry Clin Neurosci 1993; 243(3-4): 179-88.
[http://dx.doi.org/10.1007/BF02190725] [PMID: 8117762]
[80]
Williams K, Reynolds MF. Sexual dysfunction in major depression. CNS Spectr 2006; 11(8)(Suppl. 9): 19-23.
[http://dx.doi.org/10.1017/S1092852900026729] [PMID: 16871134]
[81]
Baldwin DS, Foong T. Antidepressant drugs and sexual dysfunction. Br J Psychiatry 2013; 202(6): 396-7.
[http://dx.doi.org/10.1192/bjp.bp.112.110650] [PMID: 23732933]
[82]
Fabre LF, Clayton AH, Smith LC, Goldstein IM, Derogatis LR. Association of major depression with sexual dysfunction in men. J Neuropsychiatry Clin Neurosci 2013; 25(4): 308-18.
[http://dx.doi.org/10.1176/appi.neuropsych.12010004] [PMID: 23645187]
[83]
Gelenberg AJ, Dunner DL, Rothschild AJ, Pedersen R, Dorries KM, Ninan PT. Sexual functioning in patients with recurrent major depres-sive disorder enrolled in the PREVENT study. J Nerv Ment Dis 2013; 201(4): 266-73.
[http://dx.doi.org/10.1097/NMD.0b013e318288d298] [PMID: 23538970]
[84]
IsHak WW, Mirocha J, James D, et al. Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up. Acta Psychiatr Scand 2015; 131(1): 51-60.
[http://dx.doi.org/10.1111/acps.12301] [PMID: 24954156]
[85]
Hall E, Burt VK. Male fertility: Psychiatric considerations. Fertil Steril 2012; 97(2): 434-9.
[http://dx.doi.org/10.1016/j.fertnstert.2011.11.027] [PMID: 22177463]
[86]
Aagaard L, Hansen EH. Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011. BMC Pharmacol Toxicol 2013; 14(1): 30.
[http://dx.doi.org/10.1186/2050-6511-14-30] [PMID: 23763896]
[87]
Outhoff K. Antidepressant-induced sexual dysfunction. S Afr Fam Pract 2009; 51(4): 298-302.
[http://dx.doi.org/10.1080/20786204.2009.10873868]
[88]
Alphs HH, McVary KT. Drugs that affect sexual function. Contemp Treat Erectile Dysfunct 2011; 2000(3): 81-91.
[http://dx.doi.org/10.1007/978-1-60327-536-1_7]
[89]
Balon R. SSRI-associated sexual dysfunction. Am J Psychiatry 2006; 163(9): 1504-9.
[http://dx.doi.org/10.1176/ajp.2006.163.9.1504] [PMID: 16946173]
[90]
Drobnis EZ, Nangia AK. Psychotropics and male reproduction. 2017; pp. 63-101.
[http://dx.doi.org/10.1007/978-3-319-69535-8_8]
[91]
Nudell DM, Monoski MM, Lipshultz LI. Common medications and drugs: How they affect male fertility. Urol Clin North Am 2002; 29(4): 965-73.
[http://dx.doi.org/10.1016/S0094-0143(02)00079-4] [PMID: 12516765]
[92]
Dabbous Z, Atkin SL. Hyperprolactinaemia in male infertility: Clinical case scenarios. Arab J Urol 2017; 16(1): 44-52.
[http://dx.doi.org/10.1016/j.aju.2017.10.002] [PMID: 29713535]
[93]
Semet M, Paci M, Saïas-Magnan J, et al. The impact of drugs on male fertility: A review. Andrology 2017; 5(4): 640-63.
[http://dx.doi.org/10.1111/andr.12366] [PMID: 28622464]
[94]
Higgins A, Nash M, Lynch AM. Antidepressant-associated sexual dysfunction: Impact, effects, and treatment. Drug Healthc Patient Saf 2010; 2(1): 141-50.
[http://dx.doi.org/10.2147/DHPS.S7634] [PMID: 21701626]
[95]
Bull SA, Hunkeler EM, Lee JY, et al. Discontinuing or switching selective serotonin-reuptake inhibitors. Ann Pharmacother 2002; 36(4): 578-84.
[http://dx.doi.org/10.1345/aph.1A254] [PMID: 11918502]
[96]
Safarinejad MR. Evaluation of endocrine profile and hypothalamic-pituitary-testis axis in selective serotonin reuptake inhibitor-induced male sexual dysfunction. J Clin Psychopharmacol 2008; 28(4): 418-23.
[http://dx.doi.org/10.1097/JCP.0b013e31817e6f80] [PMID: 18626269]
[97]
Clayton AH, El Haddad S, Iluonakhamhe JP, Ponce MC, Schuck AE. Sexual dysfunction associated with major depressive disorder and antidepressant treatment. Expert Opin Drug Saf 2014; 13(10): 1361-74.
[http://dx.doi.org/10.1517/14740338.2014.951324] [PMID: 25148932]
[98]
Giuliano F, Droupy S. La iatrogénie médicamenteuse en médecine sexuelle. Prog Urol 2013; 23(9): 804-10.
[http://dx.doi.org/10.1016/j.purol.2013.01.008] [PMID: 23830275]
[99]
Banerjee SP, Kung LS, Riggi SJCS, Chanda SK. Development of β-adrenergic receptor subsensitivity by antidepressants. Nature 1977; 268(5619): 455-6.
[http://dx.doi.org/10.1038/268455a0] [PMID: 197419]
[100]
Peroutka SJ, Snyder SH. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science (80- ) 1980; 210(4465): 88-90.
[http://dx.doi.org/10.1126/science.6251550]
[101]
Johnson RG, Severin CM, Rabin RA. Serotonergic binding in the rat dorsal raphe nucleus: Critical role of MAO inhibition. J Pharmacol Toxicol Methods 1996; 36(2): 81-5.
[http://dx.doi.org/10.1016/S1056-8719(96)00092-5] [PMID: 8912226]
[102]
Kumar VS, Sharma VL, Tiwari P, et al. The spermicidal and antitrichomonas activities of SSRI antidepressants. Bioorg Med Chem Lett 2006; 16(9): 2509-12.
[http://dx.doi.org/10.1016/j.bmcl.2006.01.078] [PMID: 16464584]
[103]
Bataineh HN, Daradka T. Effects of long-term use of fluoxetine on fertility parameters in adult male rats. Neuroendocrinol Lett 2007; 28(3): 321-5.
[PMID: 17627270]
[104]
Alzahrani HA. Sister chromatid exchanges and sperm abnormalities produced by antidepressant drug fluoxetine in mouse treated in vivo. Eur Rev Med Pharmacol Sci 2012; 16(15): 2154-61.
[PMID: 23280034]
[105]
Galal AAA, Alam RTM, Abd El-Aziz RM. Adverse effects of long-term administration of fluvoxamine on haematology, blood biochemis-try and fertility in male albino rats: A possible effect of cessation. Andrologia 2016; 48(9): 914-22.
[http://dx.doi.org/10.1111/and.12532] [PMID: 26771175]
[106]
Sakr HF, Abbas AM, Elsamanoudy AZ, Ghoneim FM. Effect of fluoxetine and resveratrol on testicular functions and oxidative stress in a rat model of chronic mild stress-induced depression. J Physiol Pharmacol 2015; 66(4): 515-27.
[PMID: 26348076]
[107]
Atli O, Baysal M, Aydogan-Kilic G, et al. Sertraline-induced reproductive toxicity in male rats: Evaluation of possible underlying mecha-nisms. Asian J Androl 2017; 19(6): 672-9.
[http://dx.doi.org/10.4103/1008-682X.192637] [PMID: 27976631]
[108]
Attia SM, Bakheet SA. Citalopram at the recommended human doses after long-term treatment is genotoxic for male germ cell. Food Chem Toxicol 2013; 53: 281-5.
[http://dx.doi.org/10.1016/j.fct.2012.11.051] [PMID: 23232079]
[109]
Ilgin S, Kilic G, Baysal M, et al. Citalopram induces reproductive toxicity in male rats. Birth Defects Res 2017; 109(7): 475-85.
[http://dx.doi.org/10.1002/bdr2.1010] [PMID: 28398617]
[110]
Tanrikut C, Schlegel PN. Antidepressant-associated changes in semen parameters. Urology 2007; 69(1): 185.e5-7.
[http://dx.doi.org/10.1016/j.urology.2006.10.034] [PMID: 17270655]
[111]
Elnazer HY, Baldwin DS. Treatment with citalopram, but not with agomelatine, adversely affects sperm parameters: A case report and translational review. Acta Neuropsychiatr 2014; 26(2): 125-9.
[http://dx.doi.org/10.1017/neu.2013.60] [PMID: 24855891]
[112]
Safarinejad MR. Sperm DNA damage and semen quality impairment after treatment with selective serotonin reuptake inhibitors detected using semen analysis and sperm chromatin structure assay. J Urol 2008; 180(5): 2124-8.
[http://dx.doi.org/10.1016/j.juro.2008.07.034] [PMID: 18804223]
[113]
Tanrikut C, Feldman AS, Altemus M, Paduch DA, Schlegel PN. Adverse effect of paroxetine on sperm. Fertil Steril 2010; 94(3): 1021-6.
[http://dx.doi.org/10.1016/j.fertnstert.2009.04.039] [PMID: 19515367]
[114]
Koyuncu H, Serefoglu EC, Yencilek E, Atalay H, Akbas NB. Sarıca K. Escitalopram treatment for premature ejaculation has a negative effect on semen parameters. Int J Impot Res 2011; 23(6): 257-61.
[http://dx.doi.org/10.1038/ijir.2011.35] [PMID: 21776003]
[115]
Akasheh G, Sirati L, Noshad Kamran AR, Sepehrmanesh Z. Comparison of the effect of sertraline with behavioral therapy on semen pa-rameters in men with primary premature ejaculation. Urology 2014; 83(4): 800-4.
[http://dx.doi.org/10.1016/j.urology.2013.12.004] [PMID: 24529582]
[116]
Relwani R, Berger D, Santoro N, et al. Semen parameters are unrelated to BMI but vary with SSRI use and prior urological surgery. Reprod Sci 2011; 18(4): 391-7.
[http://dx.doi.org/10.1177/1933719110385708] [PMID: 20959643]
[117]
Jing E, Straw-Wilson K. Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative litera-ture review. Ment Health Clin 2016; 6(4): 191-6.
[http://dx.doi.org/10.9740/mhc.2016.07.191] [PMID: 29955469]
[118]
Mir S, Taylor D. Sexual adverse effects with new antidepressants. Psychiatr Bull 1998; 22(7): 438-41.
[http://dx.doi.org/10.1192/pb.22.7.438]
[119]
Saleem U, Zubair S, Riaz A, Anwar F, Ahmad B. Effect of venlafaxine, pramipexole, and valsartan on spermatogenesis in male rats. ACS Omega 2020; 5(32): 20481-90.
[http://dx.doi.org/10.1021/acsomega.0c02587] [PMID: 32832801]
[120]
Urra JA, Villaroel-Espíndola F, Covarrubias AA, Rodríguez-Gil JE, Ramírez-Reveco A, Concha II. Presence and function of dopamine transporter (DAT) in stallion sperm: Dopamine modulates sperm motility and acrosomal integrity. PLoS One 2014; 9(11): e112834.
[http://dx.doi.org/10.1371/journal.pone.0112834] [PMID: 25402186]
[121]
Cavariani MM, de Almeida Kiguti LR, de Lima Rosa J, et al. Bupropion treatment increases epididymal contractility and impairs sperm quality with no effects on the epididymal sperm transit time of male rats. J Appl Toxicol 2015; 35(9): 1007-16.
[http://dx.doi.org/10.1002/jat.3089] [PMID: 25645087]
[122]
Montagnini BG, Silva LS, dos Santos AH, et al. Effects of repeated administration of methylphenidate on reproductive parameters in male rats. Physiol Behav 2014; 133: 122-9.
[http://dx.doi.org/10.1016/j.physbeh.2014.05.016] [PMID: 24866909]
[123]
Fazelipour S, Jahromy MH, Tootian Z, Kiaei SB, Sheibani MT, Talaee N. The effect of chronic administration of methylphenidate on mor-phometric parameters of testes and fertility in male mice. J Reprod Infertil 2012; 13(4): 232-6.
[PMID: 23926551]
[124]
Fazelipour S, Tootian Z, Saremi ZG, et al. Evaluation of histopathologic and histomorphometric changes of testicular tissue and gonado-tropin levels following consumption of methylphenidate in male mice. Turk J Med Sci 2014; 44(4): 554-9.
[http://dx.doi.org/10.3906/sag-1301-109] [PMID: 25551921]
[125]
Cansu A, Ekinci O, Ekinci O, et al. Methylphenidate has dose-dependent negative effects on rat spermatogenesis: Decreased round sper-matids and testicular weight and increased p53 expression and apoptosis. Hum Exp Toxicol 2011; 30(10): 1592-600.
[http://dx.doi.org/10.1177/0960327110394224] [PMID: 21183565]
[126]
Adriani W, Leo D, Guarino M, et al. Short-term effects of adolescent methylphenidate exposure on brain striatal gene expression and sexual/endocrine parameters in male rats. Ann N Y Acad Sci 2006; 1074(1): 52-73.
[http://dx.doi.org/10.1196/annals.1369.005] [PMID: 17105903]
[127]
Bellentani FF, Fernandes GSA, Perobelli JE, et al. Acceleration of sperm transit time and reduction of sperm reserves in the epididymis of rats exposed to sibutramine. J Androl 2011; 32(6): 718-24.
[http://dx.doi.org/10.2164/jandrol.111.013466] [PMID: 21764897]
[128]
Nojimoto FD, Piffer RC, Kiguti LR de A, et al. Multiple effects of sibutramine on ejaculation and on vas deferens and seminal vesicle contractility. Toxicol Appl Pharmacol 2009; 239(3): 233-40.
[http://dx.doi.org/10.1016/j.taap.2009.05.021] [PMID: 19482040]
[129]
Montejo AL, Perahia DGS, Spann ME, et al. Sexual function during long-term duloxetine treatment in patients with recurrent major de-pressive disorder. J Sex Med 2011; 8(3): 773-82.
[http://dx.doi.org/10.1111/j.1743-6109.2010.02113.x] [PMID: 21091877]
[130]
Citrome L. Levomilnacipran for major depressive disorder: A systematic review of the efficacy and safety profile for this newly approved antidepressant--what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Int J Clin Pract 2013; 67(11): 1089-104.
[http://dx.doi.org/10.1111/ijcp.12298] [PMID: 24016209]
[131]
Mago R, Mahajan R, Thase ME. Levomilnacipran: A newly approved drug for treatment of major depressive disorder. Expert Rev Clin Pharmacol 2014; 7(2): 137-45.
[http://dx.doi.org/10.1586/17512433.2014.889563] [PMID: 24524592]
[132]
Sambunaris A, Bose A, Gommoll CP, Chen C, Greenberg WM, Sheehan DV. A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorder. J Clin Psychopharmacol 2014; 34(1): 47-56.
[http://dx.doi.org/10.1097/JCP.0000000000000060] [PMID: 24172209]
[133]
Antidepressants BS. Mechanism of action, toxicity and possible amelioration. J Appl Biotechnol Bioeng 2017; 3(5): 437-48.
[134]
Levin RM, Amsterdam JD, Winokur A, Wein AJ. Babitts Fund for Psychoneuroendocrinology. Effects of psychotropic drugs on human sperm motility. Fertil Steril 1981; 36(4): 503-6.
[http://dx.doi.org/10.1016/S0015-0282(16)45801-2] [PMID: 6793407]
[135]
Bandegi L, Anvari M, Vakili M, Khoradmehr A, Mirjalili A, Talebi AR. Effects of antidepressants on parameters, melondiadehyde, and diphenyl-2-picryl-hydrazyl levels in mice spermatozoa. Int J Reprod Biomed (Yazd) 2018; 16(6): 365-72.
[http://dx.doi.org/10.29252/ijrm.16.6.365] [PMID: 30123864]
[136]
Chowdary PSRM, Rao MS. Cytogenetic effects of amitriptyline hydrochloride in somatic and germ cells of mice. Toxicol Lett 1987; 39(2-3): 199-204.
[http://dx.doi.org/10.1016/0378-4274(87)90233-5] [PMID: 3686550]
[137]
Hassanane MS, Hafiz N, Radwan W, El-Ghor AA. Genotoxic evaluation for the tricyclic antidepressant drug, amitriptyline. Drug Chem Toxicol 2012; 35(4): 450-5.
[http://dx.doi.org/10.3109/01480545.2011.642382] [PMID: 22251041]
[138]
Padrón RS, Nodarse M. Effects of amitriptyline on semen of infertile men. Br J Urol 1980; 52(3): 226-8.
[http://dx.doi.org/10.1111/j.1464-410X.1980.tb02964.x] [PMID: 7426983]
[139]
Maier U, Koinig G. Andrological findings in young patients under long-term antidepressive therapy with clomipramine. Psychopharmacology (Berl) 1994; 116(3): 357-9.
[http://dx.doi.org/10.1007/BF02245340] [PMID: 7892427]
[140]
Harrison WM, Rabkin JGEA, Ehrhardt AA, et al. Effects of antidepressant medication on sexual function: A controlled study. J Clin Psychopharmacol 1986; 6(3): 144-9.
[http://dx.doi.org/10.1097/00004714-198606000-00004] [PMID: 3711364]
[141]
Philipp M, Kohnen R, Benkert O. A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. Int Clin Psychopharmacol 1993; 7(3-4): 149-53.
[http://dx.doi.org/10.1097/00004850-199300730-00005] [PMID: 8468436]
[142]
Yamada M, Yasuhara H. Clinical pharmacology of MAO inhibitors: Safety and future. Neurotoxicology 2004; 25(1-2): 215-21.
[http://dx.doi.org/10.1016/S0161-813X(03)00097-4] [PMID: 14697896]
[143]
Kalász H, Thuróczy J, Karvaly G, et al. Effects on Sperms’ quality of selegiline in aged rats. Open Med Chem J 2017; 11(1): 138-45.
[http://dx.doi.org/10.2174/1874104501711010138] [PMID: 29387272]
[144]
Mihalik J, Mašlanková J, Solár P, et al. The effect of R-(-)-deprenyl administration on reproductive parameters of rat males. Eur J Pharmacol 2015; 754: 148-52.
[http://dx.doi.org/10.1016/j.ejphar.2015.02.030] [PMID: 25725114]
[145]
Gholamzadeh M, Shariati M, Moghadamnia D. Effect of tranylcypromine on spermatogenesis in adult Male rats. Iran J Toxicol 2019; 13(1): 9-12.
[http://dx.doi.org/10.32598/IJT.13.1.575.2]
[146]
Munjack DJ, Kanno PH. Retarded ejaculation: A review. Arch Sex Behav 1979; 8(2): 139-50.
[http://dx.doi.org/10.1007/BF01541234] [PMID: 112949]
[147]
Citrome L, Goldberg JF, Portland KB. Placing transdermal selegiline for major depressive disorder into clinical context: Number needed to treat, number needed to harm, and likelihood to be helped or harmed. J Affect Disord 2013; 151(2): 409-17.
[http://dx.doi.org/10.1016/j.jad.2013.06.027] [PMID: 23890583]
[148]
Anttila SAK, Leinonen EVJ. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 2001; 7(3): 249-64.
[http://dx.doi.org/10.1111/j.1527-3458.2001.tb00198.x] [PMID: 11607047]
[149]
Fasipe OJ. Neuropharmacological classification of antidepressant agents based on their mechanisms of action. Arch Med Heal Sci 2018; 6(1): 81-94.
[http://dx.doi.org/10.4103/amhs.amhs_7_18]
[150]
Guardiola-Lemaitre B, De Bodinat C, Delagrange P, Millan MJ, Munoz C, Mocaër E. Agomelatine: Mechanism of action and pharmacolog-ical profile in relation to antidepressant properties. Br J Pharmacol 2014; 171(15): 3604-19.
[http://dx.doi.org/10.1111/bph.12720] [PMID: 24724693]
[151]
Cassidy SL, Pearson RM. Effects of trazodone and nadolol upon human sperm motility. Br J Clin Pharmacol 1986; 22(1): 119-21.
[PMID: 3741721]
[152]
Ilgin S, Aydoǧan-Kiliç G, Baysal M, et al. Toxic effects of trazodone on male reproductive system via disrupting hypothalamic-pituitary-testicular axis and inducing testicular oxidative stress. Oxid Med Cell Longev 2018; 2018: 1-12.
[http://dx.doi.org/10.1155/2018/7196142]
[153]
El-Sisi AE, El-Sayad ME, Abdelsalam NM. Protective effects of mirtazapine and chrysin on experimentally induced testicular damage in rats. Biomed Pharmacother 2017; 95: 1059-66.
[http://dx.doi.org/10.1016/j.biopha.2017.09.022] [PMID: 28922723]
[154]
Schüle C, Baghai T, Laakmann G. Mirtazapine decreases stimulatory effects of reboxetine on cortisol, adrenocorticotropin and prolactin secretion in healthy male subjects. Neuroendocrinology 2004; 79(1): 54-62.
[http://dx.doi.org/10.1159/000076046] [PMID: 14755134]
[155]
Waldinger MD, Zwinderman AH, Olivier B. Antidepressants and ejaculation: A double-blind, randomized, fixed-dose study with mirtazapine and paroxetine. J Clin Psychopharmacol 2003; 23(5): 467-70.
[http://dx.doi.org/10.1097/01.jcp.0000088904.24613.e4] [PMID: 14520123]
[156]
Montejo AL, Deakin JFW, Gaillard R, et al. Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale. J Psychopharmacol 2015; 29(10): 1119-28.
[http://dx.doi.org/10.1177/0269881115599385] [PMID: 26268533]
[157]
Okigbo RN, Mmeka EC, State A. An Appraisal of Phytomedicine in Africa. KM ITL Sci Technol J 2006; 6(2): 83-94.
[158]
Rates SMK. Plants as source of drugs. Toxicon 2001; 39(5): 603-13.
[http://dx.doi.org/10.1016/S0041-0101(00)00154-9] [PMID: 11072038]
[159]
Light ME, Sparg SG, Stafford GI, van Staden J. Riding the wave: South Africa’s contribution to ethnopharmacological research over the last 25 years. J Ethnopharmacol 2005; 100(1-2): 127-30.
[http://dx.doi.org/10.1016/j.jep.2005.05.028] [PMID: 15994041]
[160]
Patwardhan B, Warude D, Pushpangadan P, Bhatt N. Ayurveda and traditional Chinese medicine: A comparative overview. Evid Based Complement Alternat Med 2005; 2(4): 465-73.
[http://dx.doi.org/10.1093/ecam/neh140] [PMID: 16322803]
[161]
Jung JH, Seo JT. Empirical medical therapy in idiopathic male infertility: Promise or panacea? Clin Exp Reprod Med 2014; 41(3): 108-14.
[http://dx.doi.org/10.5653/cerm.2014.41.3.108] [PMID: 25309854]
[162]
Tahvilzadeh M, Hajimahmoodi M, Toliyat T, Karimi M, Rahimi R. An evidence-based approach to medicinal plants for the treatment of sperm abnormalities in traditional Persian medicine. Andrologia 2016; 48(8): 860-79.
[http://dx.doi.org/10.1111/and.12676] [PMID: 27681644]
[163]
Sharef A, Aziz F, Adham A. The protective effect of Fumaria officinalis against the testicular toxicity of fluoxetine in rat. Zanco J Med Sci 2020; 24(1): 117-31.
[http://dx.doi.org/10.15218/zjms.2020.015]
[164]
Noorafshan A, Ashkani-Esfahani S. A review of therapeutic effects of curcumin. Curr Pharm Des 2013; 19(11): 2032-46.
[PMID: 23116311]
[165]
Sakr S, Mahran H, ElDeeb M. Ameliorative effect of curcumin on fluoxetine-induced reproductive toxicity and oxidative stress in male albino rats. Oxid Antioxid Med Sci 2013; 2(1): 29-35.
[http://dx.doi.org/10.5455/oams.140213.or.027]
[166]
Kulkarni SK, Bhutani MK, Bishnoi M. Antidepressant activity of curcumin: Involvement of serotonin and dopamine system. Psychopharmacology (Berl) 2008; 201(3): 435-42.
[http://dx.doi.org/10.1007/s00213-008-1300-y] [PMID: 18766332]
[167]
Hajizadeh Z, Mehranjani MS, Najafi G, Ali SM, Jalali AS. Black grape seed extract modulates fluoxetine-induced oxidative stress and cytotoxicity in the mouse testis. Jundishapur J Nat Pharm Prod 2016; 11(2): e27512.
[http://dx.doi.org/10.17795/jjnpp-27512]
[168]
Waggas AM. Grape seed extract (Vitis vinifera) alleviate neurotoxicity and hepatotoxicity induced by lead acetate in male albino rats. J Behav Brain Sci 2012; 02(02): 176-84.
[http://dx.doi.org/10.4236/jbbs.2012.22021]
[169]
Shim YY, Gui B, Arnison PG, Wang Y, Reaney MJ. Flaxseed (Linum usitatissimum L.) bioactive compounds and peptide nomenclature: A review. Trends Food Sci Technol 2014; 38(1): 5-20.
[http://dx.doi.org/10.1016/j.tifs.2014.03.011]
[170]
Hamedi A, Mohagheghzadeh A, Rivaz S. Preliminary pharmacognostic evaluation and volatile constituent analysis of spathe of Phoenix dactylifera L.(Tarooneh). Pharmacogn J 2013; 5(2): 83-6.
[http://dx.doi.org/10.1016/j.phcgj.2013.02.005]
[171]
Almatroodi SA, Almatroudi A, Alsahli MA, Rahmani AH. Fenugreek (Trigonella foenum graecum) and its active compounds: A review of its effects on human health through modulating biological activities. Pharmacogn J 2021; 13(3): 813-21.
[http://dx.doi.org/10.5530/pj.2021.13.103]
[172]
Datta AK, Saha A, Bhattacharya A, Mandal A, Paul R, Sengupta S. Black cumin (Nigella sativa L.) A review. J Plant Dev Sci 2012; 4(1): 1-43.
[173]
Saini D, Rawat N, Negi T, Barthwal R, Sharma SK. Utilization, valorization and functional properties of wild apricot kernels. J Pharmacogn Phytochem 2021; 10(4): 119-26.
[174]
Yazdani D, Rezazadeh SH, Amin GH, Abidin Z, Shahnazi S, Jamalifar H. Antifungal activity of dried extracts of anise (Pimpinella anisum L.) and star anise (Illicium verum Hook. f.) against dermatophyte and saprophyte fungi. Faslnamah-i Giyahan-i Daruyi 2009; 8(29): 24-9.
[175]
Mohamed AE, Abdur R. MCinnamon bark as antibacterial agent: A mini-review. GSC Biological and Pharmaceutical Sciences 2020; 10(1): 103-8.
[http://dx.doi.org/10.30574/gscbps.2020.10.1.0012]
[176]
Balubid SA, Batarfi NM. Protective effect of some herbs extracts upon the gonad of born rats treated with anti depression fluoxetine. Adv Environ Biol 2016; 10(1): 184-94.
[177]
El-Sheikh S, Khairy M, Abdel Fadil H, Abo-Elmaaty A. Ameliorative effect of Moringa oleifera extract on male fertility in paroxetine treated rats. Zagazig Vet J 2016; 44(3): 244-50.
[http://dx.doi.org/10.21608/zvjz.2016.7878]
[178]
Ganguly R, Guha D. Alteration of brain monoamines & EEG wave pattern in rat model of Alzheimer’s disease & protection by Moringa oleifera. Indian J Med Res 2008; 128(6): 744-51.
[PMID: 19246799]
[179]
Atoyebi AR. Brysocarpus coccineus (Schum & Thonn) root reinstates sexual competence and testicular function in paroxetine- induced sexual dysfunction in male Wistar rats. Andrologia 2018; 50(4): 1-17.
[180]
Yakubu MT, Jimoh RO. Aqueous extract of Carpolobia lutea root ameliorates paroxetine-induced anti-androgenic activity in male rats. Middle East Fertil Soc J 2015; 20(3): 192-7.
[http://dx.doi.org/10.1016/j.mefs.2014.10.001]
[181]
Hussien MO. Effect of propolis on reproductive hormones of selective serotonin reuptake inhibitors (SSRIS) -induced sexual dysfunction in male wistar rats. Khartoum Med J 2019; 12(3): 1644-50.
[182]
Nanaware S, Shelar M, Sinnathambi A, Mahadik KR, Lohidasan S. Neuroprotective effect of Indian propolis in β-amyloid induced memory deficit: Impact on behavioral and biochemical parameters in rats. Biomed Pharmacother 2017; 93: 543-53.
[http://dx.doi.org/10.1016/j.biopha.2017.06.072] [PMID: 28686968]
[183]
Nurudeen QO, Ajiboye TO. Aqueous root extract of Lecaniodiscus cupanioides restores the alterations in testicular parameters of sexually impaired male rats. Asian Pac J Reprod 2012; 1(2): 120-4.
[http://dx.doi.org/10.1016/S2305-0500(13)60062-7]
[184]
Sayed D. The protective effect of Nigella sativa oil against reproductive toxicity, hormonal alterations, and oxidative damage induced by Sertraline in male rats. Egypt J Exp Biol Zool 2019; 15(1): 59-67.
[http://dx.doi.org/10.5455/egysebz.20190325113108]
[185]
Folarin R. Nigella sativa prevented Parkinson’s-like motor functions impairment, dopamine depletion and neuronal degeneration in the striatum of MPTP- induced balb/c mice. In: Res Sq. 2021; pp. 1-18. [Reprint]
[186]
Morshedi F, Morovvati H, Sadeghinezhad J, Taheri M, Anbara H. Evaluation of sperm quality and serum parameters in sertraline-exposed mice and protective role of vitamin E. Majallah-i Danishgah-i Ulum-i Pizishki-i Babul 2020; 22(1): 1-8.
[187]
Castaño A, Herrera AJ, Cano J, Machado A. Effects of a short period of vitamin E-deficient diet in the turnover of different neurotransmit-ters in substantia nigra and striatum of the rat. Neuroscience 1993; 53(1): 179-85.
[http://dx.doi.org/10.1016/0306-4522(93)90296-R] [PMID: 7682297]
[188]
Rana S, Kamboj JK, Gandhi V. Living life the natural way-Wheatgrass and Health. Funct Food Health Dis 2011; 1(11): 444-56.
[http://dx.doi.org/10.31989/ffhd.v1i11.112]
[189]
Hamdi H. The preventive role of wheat germ oil against sertraline-induced testicular damage in male albino rats. Andrologia 2019; 51(10): e13369.
[http://dx.doi.org/10.1111/and.13369] [PMID: 31418462]
[190]
Shaalan S, Radwan O, Saleh H. Role of wheat germ oil against carbon tetrachloride-induced neurotoxicity in brain tissues of adult male mice. Egypt J Zool 2017; 67(67): 1-18.
[http://dx.doi.org/10.12816/0037791]
[191]
Besong EB, Ateufack G, Babiaka SB, Kamanyi A. Leaf-methanolic extract of Pseudopanax arboreus (Araliaceae) (L. F. Phillipson) Re-verses amitriptyline-induced sexual dysfunction in male rats. Biochem Res Int 2018; 2018: 2869727.
[http://dx.doi.org/10.1155/2018/2869727] [PMID: 30581624]
[192]
Bicchi C, Rubiolo P, Saranz Camargo EE, Vilegas W, de Souza Gracioso J, Monteiro Souza Brito AR. Components of Turnera diffusa willd. var. afrodisiaca (Ward) Urb. essential oil. Flavour Fragrance J 2003; 18(1): 59-61.
[http://dx.doi.org/10.1002/ffj.1155]
[193]
Tousson E, Hafez E, Zaki S, Gad A, Elgharabawy RM. Evaluation of the testicular protection conferred by damiana (Turnera diffusa Willd.) against amitriptyline-induced testicular toxicity, DNA damage and apoptosis in rats. Biomed Pharmacother 2020; 132: 110819.
[http://dx.doi.org/10.1016/j.biopha.2020.110819] [PMID: 33035829]

Rights & Permissions Print Cite
Article Metrics
13
© 2024 Bentham Science Publishers | Privacy Policy